Reviva Pharmaceuticals Holdings Dirección
Dirección controles de criterios 1/4
Actualmente no disponemos de información suficiente sobre el CEO.
Información clave
Laxminarayan Bhat
Chief Executive Officer (CEO)
US$2.6m
Compensación total
Porcentaje del salario del CEO | 17.3% |
Permanencia del CEO | 17.9yrs |
Participación del CEO | 8.9% |
Permanencia media de la dirección | sin datos |
Promedio de permanencia en la Junta Directiva | 3.3yrs |
Actualizaciones recientes de la dirección
Recent updates
Here's Why Reviva Pharmaceuticals Holdings (NASDAQ:RVPH) Must Use Its Cash Wisely
Aug 24We're Keeping An Eye On Reviva Pharmaceuticals Holdings' (NASDAQ:RVPH) Cash Burn Rate
Dec 28Reviva Pharmaceuticals drops 9% on $8.5M private placement
Sep 06We're A Little Worried About Reviva Pharmaceuticals Holdings' (NASDAQ:RVPH) Cash Burn Rate
Aug 24Reviva Pharmaceuticals Q2 GAAP loss per share widens
Aug 15Reviva reports positive brilaroxazine results in Aacute Schizophrenia
Apr 26Análisis de compensación del CEO
Fecha | Compensación total | Salario | Ingresos de la empresa |
---|---|---|---|
Dec 31 2023 | US$3m | US$450k | -US$39m |
Sep 30 2023 | n/a | n/a | -US$38m |
Jun 30 2023 | n/a | n/a | -US$31m |
Mar 31 2023 | n/a | n/a | -US$24m |
Dec 31 2022 | US$560k | US$400k | -US$28m |
Sep 30 2022 | n/a | n/a | -US$20m |
Jun 30 2022 | n/a | n/a | -US$19m |
Mar 31 2022 | n/a | n/a | -US$15m |
Dec 31 2021 | US$600k | US$400k | -US$9m |
Sep 30 2021 | n/a | n/a | -US$6m |
Jun 30 2021 | n/a | n/a | -US$5m |
Mar 31 2021 | n/a | n/a | -US$4m |
Dec 31 2020 | US$248k | US$248k | -US$4m |
Sep 30 2020 | n/a | n/a | -US$2m |
Jun 30 2020 | n/a | n/a | -US$2m |
Mar 31 2020 | n/a | n/a | -US$1m |
Dec 31 2019 | US$240k | US$240k | -US$847k |
Dec 31 2018 | US$240k | US$240k | -US$2m |
Compensación vs. Mercado: La compensación total de Laxminarayan($USD2.61M) está por encima de la media de empresas de tamaño similar en el mercado US ($USD681.24K).
Compensación vs. Ingresos: La compensación de Laxminarayan ha aumentado mientras la empresa no es rentable.
CEO
Laxminarayan Bhat (58 yo)
17.9yrs
Permanencia
US$2,607,247
Compensación
Dr. Laxminarayan Bhat, Ph D., serves as the Founder of Reviva Pharmaceuticals Holdings, Inc. since 2006 and has been its Director since 2006 and serves as its President and Chief Executive Officer since Ma...
Miembros de la Junta
Nombre | Posición | Permanencia | Compensación | Propiedad |
---|---|---|---|---|
Founder | 18.3yrs | US$2.61m | 8.88% $ 7.5m | |
Independent Chairman of the Board | 3.3yrs | US$107.01k | 3.12% $ 2.6m | |
Member of Advisory Board | no data | sin datos | sin datos | |
Member of Advisory Board | no data | sin datos | sin datos | |
Independent Director | 3.3yrs | US$88.01k | sin datos | |
Independent Director | 3.3yrs | US$81.76k | sin datos | |
Member of Advisory Board | no data | sin datos | sin datos | |
Member of Advisory Board | no data | sin datos | sin datos | |
Independent Director | 6.9yrs | US$90.51k | 0.33% $ 277.2k | |
Member of Advisory Board | no data | sin datos | sin datos |
3.3yrs
Permanencia media
55yo
Promedio de edad
Junta con experiencia: La junta directiva de RVPH se considera experimentada (3 años de antigüedad promedio).